z-logo
open-access-imgOpen Access
Renal function after nephron-sparing surgery versus radical nephrectomy in localized renal cell carcinoma (T1)
Author(s) -
Siros Jitpraphai,
Chaiyong Nualyong,
Tawatchai Taweemonkongsap,
Sittiporn Srinualnad,
Teerapon Amornwesukit,
Sunai Leewansangtong,
Bansithi Chaiyaprasithi,
Ekkarin Chotikawanich,
Kittipong Phinthusophon,
Chalairat SukOuichai,
Varat Woranisarakul,
Phanpon Leelahawong
Publication year - 2020
Publication title -
insight urology
Language(s) - English
Resource type - Journals
ISSN - 2730-3217
DOI - 10.52786/j.1
Subject(s) - nephrectomy , medicine , renal cell carcinoma , urology , renal function , kidney
Objective: To evaluate renal function (GFR) after radical nephrectomy compared to partial nephrectomy in stage T1 renal cell carcinoma patients between 2005 and 2015.Material and Method: Retrospective chart review of 409 patients who were diagnosed with renal cell carcinoma (T1) and treated with radical nephrectomy (RN) or partial nephrectomy (PN) between 2005 and 2015 (RN=136, PN=92); 228 patients with pathologically confirmed pT1 remained for analysis and were then evaluated for their estimated glomerular filtration rate (eGFR) after the surgery.Results: There were a total of 228 (149 males and 79 females) T1 RCC patients; 136 patients were T1a with RN (57.8%) and 92 with PN (42.2%). Median follow-up was 58 months and 35 months for the RN and PN groups. From the analysis, post-operative eGFR of the RN group was decreased from 77.49 to 59.61 ml/min/1.73m2 and the PN group was decreased from 78.85 to 69.9 ml/min/1.73m2. The comparative eGFR between the 2 groups at 1 month had a significant difference (p-value<0.05). eGFR at 3 months (50.24 in RN vs 64.67 in PN), 6 months (47.98 vs 64.51), 3 years (48.79 vs 67.22) and 5 years (52.63 vs 73.59) were also significantly altered between the 2 groups. The tumor recurrence rate was not significantly different between RN and PN.Conclusion: We found that patients treated with PN had superior post-operative renal function compared with RN. However, there was no difference in the tumor recurrence rate between the 2 groups after a follow-up of 10 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom